Pediatrix Medical Group (MD) Competitors

Pediatrix Medical Group (NYSE:MD) and Amedisys (NASDAQ:AMED) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, earnings, analyst recommendations, valuation, dividends, community ranking, media sentiment and institutional ownership.

Which has more risk & volatility, MD or AMED?

Pediatrix Medical Group has a beta of 1.58, indicating that its share price is 58% more volatile than the S&P 500. Comparatively, Amedisys has a beta of 0.72, indicating that its share price is 28% less volatile than the S&P 500.

Do analysts rate MD or AMED?

Pediatrix Medical Group presently has a consensus price target of $16.25, indicating a potential upside of 17.40%. Amedisys has a consensus price target of $100.67, indicating a potential upside of 9.53%. Given Pediatrix Medical Group's stronger consensus rating and higher possible upside, analysts clearly believe Pediatrix Medical Group is more favorable than Amedisys.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pediatrix Medical Group	0 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Amedisys	0 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.20

Do insiders and institutionals have more ownership in MD or AMED?

97.7% of Pediatrix Medical Group shares are owned by institutional investors. Comparatively, 94.4% of Amedisys shares are owned by institutional investors. 1.2% of Pediatrix Medical Group shares are owned by company insiders. Comparatively, 2.1% of Amedisys shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Is MD or AMED more profitable?

Amedisys has a net margin of 3.57% compared to Pediatrix Medical Group's net margin of -12.65%. Pediatrix Medical Group's return on equity of 12.79% beat Amedisys' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Pediatrix Medical Group	-12.65%	12.79%	4.75%
Amedisys	3.57%	12.20%	6.74%

Does the MarketBeat Community believe in MD or AMED?

Pediatrix Medical Group received 11 more outperform votes than Amedisys when rated by MarketBeat users. Likewise, 60.31% of users gave Pediatrix Medical Group an outperform vote while only 58.72% of users gave Amedisys an outperform vote.

Company	Underperform	Outperform
Pediatrix Medical Group	Outperform Votes 506 60.31%	Underperform Votes 333 39.69%
Amedisys	Outperform Votes 495 58.72%	Underperform Votes 348 41.28%

Does the media refer more to MD or AMED?

In the previous week, Pediatrix Medical Group had 2 more articles in the media than Amedisys. MarketBeat recorded 4 mentions for Pediatrix Medical Group and 2 mentions for Amedisys. Amedisys' average media sentiment score of 0.75 beat Pediatrix Medical Group's score of 0.69 indicating that Amedisys is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Pediatrix Medical Group	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Amedisys	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has stronger earnings and valuation, MD or AMED?

Amedisys has higher revenue and earnings than Pediatrix Medical Group. Pediatrix Medical Group is trading at a lower price-to-earnings ratio than Amedisys, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pediatrix Medical Group	$1.99B	0.60	-$60.41M	-$3.06	-4.52
Amedisys	$2.32B	1.30	-$9.75M	$2.52	36.47

Summary

Pediatrix Medical Group and Amedisys tied by winning 9 of the 18 factors compared between the two stocks.